Purchases and Sales Made in Q3 2024 in Arcutis Biotherapeutics, Inc. (ARQT)
This table provides information about the institutional ownership of Arcutis Biotherapeutics, Inc. (ARQT) during Q3 2024. The information is specifically focused on institutions that hold shares of Arcutis Biotherapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 12, 2024
Q3 2024
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-188K- 4.23% |
$1.56M - $2.07M
|
4.25M
$60.4M
|
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-191K- 4.82% |
$1.59M - $2.11M
|
3.78M
$53.8M
|
|
|
May 14, 2025
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-191K- 4.82% |
$1.59M - $2.11M
|
3.78M
$53.8M
|
|
|
Nov 14, 2024
Q3 2024
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-200K- 12.83% |
$1.66M - $2.2M
|
1.36M
$19.3M
|
|
|
Nov 14, 2024
Q3 2024
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-200K- 7.92% |
$1.66M - $2.2M
|
2.33M
$33.1M
|
|
|
Nov 14, 2024
Q3 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-306K- 62.59% |
$2.54M - $3.36M
|
183K
$2.6M
|
|
|
Nov 14, 2024
Q3 2024
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-435K- 77.19% |
$3.62M - $4.78M
|
128K
$1.83M
|
|
|
Nov 14, 2024
Q3 2024
|
Two Seas Capital LP
Rye, NY |
SELL
|
- |
-450K- 59.05% |
$3.74M - $4.95M
|
312K
$4.44M
|
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-461K- 72.63% |
$3.83M - $5.07M
|
174K
$2.47M
|
|
|
Nov 12, 2024
Q3 2024
|
Trexquant Investment LP
Stamford, CT |
SELL
|
- |
-577K- 86.48% |
$4.8M - $6.35M
|
90.2K
$1.28M
|
|
|
Nov 12, 2024
Q3 2024
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-790K- 70.93% |
$6.57M - $8.69M
|
324K
$4.6M
|
|
|
Nov 13, 2024
Q3 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-1.08M- 57.49% |
$9M - $11.9M
|
800K
$11.4M
|